Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

13 mai 2026 14h47 HE | Source: The Rosen Law Firm PA

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GOSS

NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gossamer Bio, Inc. (NASDAQ: GOSS) between June 16, 2025 and...
12 mai 2026 16h49 HE | Source: Hagens Berman Sobol Shapiro LLP

GOSS Investor Alert: Gossamer Bio Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: Hagens Berman

Investors who lost money in GOSS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
10 mai 2026 19h48 HE | Source: The Rosen Law Firm PA

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GOSS

NEW YORK, May 10, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gossamer Bio, Inc. (NASDAQ: GOSS) between June 16, 2025 and...
07 mai 2026 15h58 HE | Source: The Rosen Law Firm PA

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Gossamer Bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GOSS

NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gossamer Bio, Inc. (NASDAQ: GOSS) between June 16, 2025 and...
06 mai 2026 16h53 HE | Source: Hagens Berman Sobol Shapiro LLP

INVESTOR NOTICE: Gossamer Bio, Inc. (GOSS) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action– Hagens Berman

Investors who lost money in GOSS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
04 mai 2026 10h40 HE | Source: Hagens Berman Sobol Shapiro LLP

INVESTOR NOTICE: Gossamer Bio, Inc. (GOSS) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action– Hagens Berman

Investors who lost money in GOSS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
04 mai 2026 08h47 HE | Source: Berger Montague

INVESTOR REMINDER: Berger Montague Notifies Gossamer Bio, Inc. (NASDAQ: GOSS) Investors of a Class Action Lawsuit and Deadline

PHILADELPHIA, May 04, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit against Gossamer Bio, Inc. (NASDAQ: GOSS) (“Gossamer” or the...
01 mai 2026 12h05 HE | Source: Hagens Berman Sobol Shapiro LLP

Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure– Hagens Berman

Investors who lost money in GOSS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
28 avr. 2026 19h35 HE | Source: Hagens Berman Sobol Shapiro LLP

INVESTOR NOTICE: Gossamer Bio, Inc. (GOSS) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action– Hagens Berman

Investors who lost money in GOSS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
24 avr. 2026 15h12 HE | Source: Hagens Berman Sobol Shapiro LLP

Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure– Hagens Berman

Investors who lost money in GOSS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.

Page suivante